Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The deal, which could be worth up to $870 million overall, will give Lilly access to a delivery technology that may help ...

That’s up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

Novo Nordisk ( NVO, Financials) is seeing more U.S. teens start treatment with its GLP-1 drug Wegovy; new data shows a 50% ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...